SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
SCHEDULE 13D
Under the Securities Exchange Act of 19341
ELECTROSCOPE, INC.
(Name of issuer)
COMMON STOCK, NO PAR VALUE
(Title of class of securities)
286135108
(CUSIP number)
Karl Hawkins, 4828 Sterling Drive,
BOULDER, COLORADO 80301, (303)444-2600
(Name, address and telephone number of person
authorized to receive notices and communications)
DECEMBER 29, 1997
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box.
Note. Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent.
(Continued on following pages)
(Page 1 of 7 Pages)
- ---------------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 286135108 13D Page 2 of 7 of Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Vern D. Kornelsen
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / X / /1/
3 SEC USE ONLY
4 SOURCE OF FUNDS*
AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
Not applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 366,321
OWNED BY
EACH 8 SHARED VOTING POWER
REPORTING
PERSON WITH 0
9 SOLE DISPOSITIVE POWER
366,321
10 SHARED DISPOSITIVE POWER
0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
366,321
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/ /
Not applicable
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.8%
- ----------------
1 See Item 5(b).
<PAGE>
CUSIP No. 286135108 13D Page 3 of 7 of Pages
14 TYPE OF REPORTING PERSON*
IN
<PAGE>
Page 4 of 7 of Pages
Item 1. SECURITY AND ISSUER.
This Schedule 13D is filed with respect to shares of Common Stock,
no par value ("Common Stock"), of Electroscope, Inc., a Colorado corporation
(the "Company"). The Company's principal executive offices are located at 4828
Sterling Drive, Boulder, Colorado.
Item 2. IDENTITY AND BACKGROUND.
(a), (b) and (c). This Schedule 13D is being filed by Vern D.
Kornelsen ("Kornelsen"), whose residence and business address is 4605 Denice
Drive, Englewood, Colorado 80111. The principal occupation of Kornelsen is as a
self-employed certified public accountant.
(d) and (e). Kornelsen has not, during the last five years, been (i)
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) a party to a civil proceeding of a judicial or
administrative body of a competent jurisdiction as a result of which he was or
is subject to a judgment, decree or final order enjoining future violations of
or prohibiting or mandating activities subject to, federal or state securities
laws or finding any violation with respect to such laws.
(f) Kornelsen is a citizen of the United States of America.
Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
On December 29, 1997, CMED Partners LLLP ("CMED"), of which
Kornelsen is the sole general partner, purchased 20,000 shares of the Company's
Common Stock for $1.375 per share. On December 30, 1997, CMED purchased an
additional 27,700 shares of the Company's Common Stock for $1.375 per share. On
December 31, 1997, CMED purchased another 18,300 shares of the Company's Common
Stock for $1.375 per share. On December 31, 1997, one of CMED's limited partners
transferred 30,100 shares of the Company's Common Stock to CMED which the
limited partner had previously purchased in his individual capacity.
Item 4. PURPOSE OF TRANSACTION.
Except as described below, Kornelsen has no present plans or
proposals that relate to or would result in any transaction, event or action of
the type described in paragraphs (a) through (j) of Item 4. In the future,
however, Kornelsen reserves the right to adopt such plans or proposals, subject
to applicable regulatory requirements, if any.
<PAGE>
Page 5 of 7 Pages
Depending on market conditions, Kornelsen plans to purchase an
undetermined number of additional shares of the Company from time to time.
Item 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) For the purposes of Section 13(d) of the Securities Exchange Act
of 1934 (the "Act"), Kornelsen beneficially owns 366,321 shares of Common Stock
which constitute 6.8% of the outstanding and issued Common Stock of the Company.
(b) Kornelsen owns 100,005 shares of the Company's Common Stock
individually and has sole voting and dispositive power with respect to those
shares. As President of Tienet, Inc. ("Tienet"), a Colorado corporation,
Kornelsen has sole voting and dispositive power with respect to an additional
38,216 shares of the Company's Common Stock. As the general partner of CMED,
Kornelsen has sole voting and dispositive power with respect to another 228,100
shares of the Company's Common Stock. Thus, Kornelsen has sole voting and
dispositive power with respect to 366,321 shares of the Company's Common Stock.
Although Kornelsen is President of Tienet and General Partner of
CMED, Kornelsen, pursuant to Rule 13d-4 under the Act, declares that the filing
of this schedule shall not be construed as an admission he is, for the purposes
of Sections 13(d) and 13(g) of the Act, the beneficial owner of the Company's
Common Stock owned by Tienet and CMED. Kornelsen further disclaims the existence
of a "group" within the meaning of Section 13(d)(3) of the Act as there is no
agreement amongst Kornelsen, Tienet or CMED to act together for the purposes of
acquiring, holding, voting or disposing of the Company's Common Stock.
(c) None.
(d) Not applicable.
(e) Not applicable.
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
See Item 5(b) above for a description of Kornelsen's voting and
dispositive power as President of Tienet and General Partner of CMED.
<PAGE>
Page 6 of 7 Pages
Item 7. MATERIAL TO BE FILED AS EXHIBITS.
Not applicable.
<PAGE>
Page 7 of 7 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
the undersigned hereby certifies that the information as set forth in this
initial filing is true, complete and correct.
/s/ Vern D. Kornelsen
--------------------------------------
Vern D. Kornelsen
Dated: January 8, 1998
